Author = Nagla Abdel Karim
A Phase I Trial to Determine the Safety and Tolerability of Autophagy Inhibition Using Chloroquine or Hydroxychloroquine in Combination with Carboplatin and Gemcitabine in Patients with Advanced Solid Tumorsced solid tumors.

Volume 26, Issue 4, April 2025, Pages 1165-1172

Nagla Abdel Karim; Ihab Eldessouki; Imran Ahmed; Ola Gaber; Elmustapha Bahassi; Ahmed Khaled; Harlod Davis; John C Morris


Stenting in Non-Small Cell Lung Cancer: How Does It Affect the Outcomes?

Volume 21, Issue 1, January 2020, Pages 175-178

Nagla Abdel Karim; Sinan Khaddasn; Mahmoud Shehata; Ahmed Mostafa; Mohamed Magdy; Ihab Eldessouki; Changchun Xie; Sadia Benzequene


Exosomes as a Surrogate Marker for Autophagy in Peripheral Blood, Correlative Data from Phase I Study of Chloroquine in Combination with Carboplatin/Gemcitabine in Advanced Solid Tumors

Volume 20, Issue 12, December 2019, Pages 3789-3796

Nagla Abdel Karim; Ola Gaber; Hashim M Aljohani; Ihab Eldessouki; El Mustapha Bahassi; John Morris